Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... study appears online and is scheduled for print publication later in the journal Brain, Behavior, and Immunity. She and colleagues also recently published a study ... Blood samples were taken to measure levels of two proteins, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-a). Both are proinflammatory cytokines, chemical messengers ...
2009 NOV 23 ... was observed between EGFR mutations and overall survival (P = 0.39). Isolated brain metastasis as the first recurrence after resection was found more frequently in those ... were more frequently found in never-smoker (P = 0.04) or in smaller-sized primary tumor (P = 0.001). A presence of EGFR mutations was significantly associated with longer ...
2009 NOV 23 ... regression models. Red cell distribution width was found to be an N-terminal pro-brain natriuretic peptide independent predictor of all-cause mortality (adjusted HR 1.61 per 1 ... receptor levels), inflammation and acute-phase reaction (interleukin-6, soluble tumor necrosis factor (TNF) receptor I and soluble TNF receptor II, C-reactive protein, and ...
2009 NOV 23 ... a 20-member panel from various medical specialties. Members of the panel analyzed 25,000 brain tumor studies and then utilized 400 of them to make their final guideline decisions. The new ...
2009 NOV 23 ... new, long-lasting form of interferon alpha, but data regarding its cognitive effects in brain tumor patients are limited." "in this study were 35 primary...
2009 NOV 23 ... in planning treatment for other disease sites such as prostate, head and neck, lung and brain. Commissioning of Philips' SmartArc technology was performed by Vladimir ... for the patient and also much more accurate by reducing intra-fraction patient/tumor motion. SmartArc will enable us to improve patient care and comfort, while increasing ...
2009 NOV 23 ... The ERCC1 status was discordant in 20 cases (41%), with a trend toward overexpression in brain and adrenal metastases (p = 0.01 and p = 0.08, respectively). The vascular-endothelial ... is increasingly advocated. The correlation of biomarker expression between the primary tumor and its corresponding metastasis has not yet been well documented and analyzed in ...
2009 NOV 23 ... comprising 2660 unique protein identifications was obtained for the proteome of a human brain tumor (glioblastoma multiforme) by combining the results of two complementary analytical ...
2009 NOV 29 ... The lipid that accumulates in brain cells of individuals with an inherited enzyme disorder also drives the cell death that ... of this disease," said Alessandra d'Azzo, Ph.D., of St. Jude Genetics and Tumor Cell Biology. She is the senior author of the report and holds the Jewelers for Children ...
2009 NOV 23 ... Jost and colleagues published their study in Molecular Imaging (Measuring Brain Tumor Growth: Combined Bioluminescence Imaging-Magnetic Resonance Imaging Strategy. Molecular ...
2009 NOV 23 ... functioning. St. Jude has the world's largest protocol-based pediatric brain tumor research and treatment program, which puts it in an excellent position to scientifically ...
2009 NOV 29 ... cells could help people with learning and memory deficits after radiation treatment for brain tumors, suggests a new UC Irvine study.Research with rats found that ...
2009 NOV 23 ... of TS. Careful analysis of tumor DNA is required to exclude the chance occurrence of a brain tumor in HNPCC kindreds and increase our understanding of the pathogenesis of the disease," ...
2009 NOV 23 ... and negatively charged liposomes were injected into the tail vein of rats, and blood/brain barrier (BBB) targeting was determined by confocal microscopy as a function of the ... Neuroinflammation, Neurology, Oncology, Pharmaceuticals, Therapy, Treatment, Tumor Vascularization. This article was prepared by Pain & Central Nervous System ...
2009 NOV 23 ... of intravenous gadolinium-DTPA on diffusion tensor MR imaging for the evaluation of brain tumors,' is now available. According to recent research from Seoul, Korea, "The aim of ... gradients were calculated. Regions of interest (ROIs) were placed in the tumor, peritumoral edema, and normal-appearing symmetric contralateral brain tissue for each ...
2009 NOV 24 ... According to a study from the United States, "Sexually dimorphic brain nuclei underlie gender-specific neural functions and susceptibility to disease, but the ... apoptosis microarrays and in vivo and in vitro follow-up studies. We found that the tumor necrosis factor alpha (TNF alpha)-TNF receptor 2 (TNFR2)-NF kappa B cell survival ...
2009 NOV 23 ... Unresectable pilocytic astrocytomas that are located in critical or deep areas of the brain require additional management approaches. In this preliminary experience obtained over a ... series was 100%, 88.9% and 88.9% at 1, 3 and 5 years, respectively. Localized solid tumor progression was seen in two patients. Cyst progression was noted in three of nine ...
2009 NOV 23 ... information, contact G.K. Friedman, University of Alabama, Dept. of Pediatrics, Brain Tumor Research Program, 1046 Tinsley Harrison Tower, 1900 University Blvd., Birmingham, AL ...
